Home

Hannah Valantine, Director: BridgeBio Pharma BBIO Planned sale · Filed 25/06/10

Trade details

Type
Planned sale notice
Planned sale date
25/06/10
Filed
25/06/10

$171.7K to be sold

BridgeBio Pharma trades, last 26 weeks

What else happened in BridgeBio Pharma around then

Filed or reported within 30 days of the trade day · 25/05/11~25/07/10

Hannah Valantine's recent trades

  • Hannah Valantine

    Planned sale10b5-1 planCareDx

    $856.2K

    Filed 07/16

  • Hannah Valantine

    Sell10b5-1 planBridgeBio Pharma

    $190.9K

    Filed 06/24

  • Hannah Valantine

    Sell10b5-1 planBridgeBio Pharma

    $150.6K

    Filed 06/24

  • Hannah Valantine

    Planned sale10b5-1 planBridgeBio Pharma

    $150.6K

    Filed 06/23

  • Hannah Valantine

    Planned sale10b5-1 planBridgeBio Pharma

    $190.9K

    Filed 06/22

Hannah Valantine, Director — plans to sell 4,292 sh of BridgeBio Pharma BBIO · $171.7K · around 06/10 · 10b5-1 plan | Whalegun